Drs. Cooper and Ailani continue their discussion from the 2024 AAN annual meeting in Denver, Colorado. In this second episode, they cover the results of the OVERCOME and TANDEM trials; understanding patients’ journeys prior to initiating CGRP inhibitors; and the prevalence and characteristics of menstrual migraines.
